AbCellera is mobilizing its pandemic response platform based on its rapid antibody discovery technology to respond to the 2019-nCoV outbreak.
AbCellera is mobilizing its pandemic response platform based on its rapid antibody discovery technology to respond to the 2019-nCoV outbreak.
Comments are closed.